Phil Newman

About

Editor-in-Chief Phil has over 25 years of C-level management, marketing and business development expertise in Europe and North America. His creative background has helped him shape unconventional strategies for commercial growth - garnering both awards and investor ROI.

Phil has wide experience of technology transfer and the commercialisation of innovations from both private and institutional sources and this led to his interest in Longevity and the founding of Longevity.Technology.
21 POSTS

/

0 COMMENTS

Articles

AgeX and Lineage granted pluripotent patent

AgeX Therapeutics and Lineage Cell Therapeutics awarded US patent for 'Method of Generating Induced Pluripotent Stem Cells'. AgeX Therapeutics, Inc. and Lineage Cell Therapeutics, Inc. today announced...

Senescence market set to hit $644m by 2023

The global longevity and anti-senescence therapies market is set to grow to $644.4 million by 2023. According to a report from Trends Market Research (published...

Interview: 3D bioprinting realties and timescales

After a unique 3D bioprinting research symposium in London we chat with UCL's expert: Dr Deepak Kalaskar  There's something about being at conferences with early-stage...

Genetic discoveries: Implications for Longevity

New genetic discoveries suggest that components of the extracellular matrix might represent a link between immune defence and Longevity: Present and future directions. Even though...

Novoheart and AstraZeneca develop heart in a jar

AstraZeneca and Novoheart have combined forces to develop a first of its kind model for a common, but much misunderstood form of heart failure. Pharma...

Senescence biomarkers identified and publicly shared

New research proposes how to use ICSA consensus as a guideline for senescence biomarkers. Since their discovery 60 years ago, significant progress has been made...

Meet Peter 2.0: One step closer to the Singularity

When Dr Peter Scott-Morgan was diagnosed with motor neurone disease, he decided to challenge what it means to be human. “Peter 2.0 is now online.”...

Longevity Week London: Key quotes and articles

Last week was a big turning point in Longevity: In key centres of academic and scientific endeavour the key players in Longevity aligned. The three intense...

Longevity Forum 2019 and the 150 year life

Leaders in the Longevity sector gather for annual Forum, with the message that people could soon be living up to 150 years. It’s the third...

Sign-up for daily news on the research, investments and technologies driving the Longevity market.

Sign-up for daily news on the research, investments and technologies driving the Longevity market.